Role of proteases in the development and diseases of the lens

Expert Review of Ophthalmology

Volumn 2, Issue 5, 2007, Pages 833-844

  Wride, Michael A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

calpain; caspase; cataract; cathepsin; development; lens; matrix metalloprotease; organelle loss; posterior capsule opacification; protease; proteasome

Indexed keywords

EID: 62749089441     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/17469899.2.5.833     Document Type: Article

References (94)

1. Hu J, Van den Steen PE, Sang QX, Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 6 (6), 480–498 (2007).
2. Zavrski I, Kleeberg L, Kaiser M et al. Proteasome as an emerging therapeutic target in cancer. Curr. Pharm. Des. 13 (5), 471–485 (2007).
3. Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr. Pharm. Des. 13 (3), 385–401 (2007).
4. Nuti E, Tuccinardi T, Rossello A. Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors. Curr. Pharm. Des. 13 (20), 2087–2100 (2007).
5. Wride MA, Geatrell J, Guggenheim JA. Proteases in eye development and disease. Birth Defects Res. C. Embryo Today 78 (1), 90–105 (2006).
6. Shiels A, Hejtmancik JF. Genetic origins of cataract. Arch. Ophthalmol. 125 (2), 165–173 (2007).
7. Foster A, Resnikoff S. The impact of Vision 2020 on global blindness. Eye 19 (10), 1133–1135 (2005).
8. Reddy MA, Francis PJ, Berry V, Bhattacharya SS, Moore AT. Molecular genetic basis of inherited cataract and associated phenotypes. Surv. Ophthalmol. 49 (3), 300–315 (2004).
9. Devgan U. Surgical techniques in phacoemulsification. Curr. Opin. Ophthalmol. 18 (1), 19–22 (2007).
10. Wormstone IM. Posterior capsule opacification: a cell biological perspective. Exp. Eye Res. 74 (3), 337–347 (2002).
11. Ellis FJ. Management of pediatric cataract and lens opacities. Curr. Opin. Ophthalmol. 13 (1), 33–37 (2002).
12. Hodge W, Horsley T, Albiani D et al. The consequences of waiting for cataract surgery: a systematic review. CMAJ 176 (9), 1285–1290 (2007).
13. Allen D, Vasavada A. Cataract and surgery for cataract. BMJ 333 (7559), 128–132 (2006).
14. Andley UP. Crystallins in the eye: function and pathology. Prog. Retin Eye Res. 26 (1), 78–98 (2007).
15. Wride MA. Cellular and molecular features of lens differentiation: a review of recent advances. Differentiation 61 (2), 77–93 (1996).
16. Bassnett S. Lens organelle degradation. Exp. Eye Res. 74 (1), 1–6 (2002).
17. Zandy AJ, Bassnett S. Proteolytic mechanisms underlying mitochondrial degradation in the ocular lens. Invest. Ophthalmol. Vis. Sci. 48 (1), 293–302 (2007).
18. Pendergrass W, Penn P, Possin D, Wolf N. Accumulation of DNA, nuclear and mitochondrial debris, and ROS at sites of age-related cortical cataract in mice. Invest. Ophthalmol. Vis. Sci. 46 (12), 4661–4670 (2005).
19. Pendergrass WR, Penn PE, Possin DE, Wolf NS. Cellular debris and ROS in age-related cortical cataract are caused by inappropriate involution of the surface epithelial cells into the lens cortex. Mol. Vis. 12, 712–724 (2006).
20. Lockshin RA, Zakeri Z. Apoptosis autophagy, and more. Int. J. Biochem. Cell Biol. 36 (12), 2405–2419 (2004).
21. Dahm R. Lens fibre cell differentiation - a link with apoptosis? Ophthalmic Res. 31 (3), 163–183 (1999).
22. Wride MA. Minireview: apoptosis as seen through a lens. Apoptosis 5 (3), 203–209 (2000).
23. Bassnett S, Mataic D. Chromatin degradation in differentiating fiber cells of the eye lens. J. Cell Biol. 137 (1), 37–49 (1997).
24. Dahm R, Prescott AR. Morphological changes and nuclear pore clustering during nuclear degradation in differentiating bovine LFCs. Ophthalmic Res. 34 (5), 288–294 (2002).
25. Zandy AJ, Lakhani S, Zheng T, Flavell RA, Bassnett S. Role of the executioner caspases during lens development. J. Biol. Chem. 280 (34), 30263–30272 (2005).
26. Sanders EJ, Parker E. The role of mitochondria, cytochrome c and caspase-9 in embryonic LFC denucleation. J. Anat. 201 (2), 121–135 (2002).
27. Wride MA, Parker E, Sanders EJ. Members of the bcl-2 and caspase families regulate nuclear degeneration during chick lens fibre differentiation. Dev. Biol. 213 (1), 142–156 (1999).
28. Ishizaki Y, Jacobson MD, Raff MC. A role for caspases in lens fiber differentiation. J. Cell Biol. 140 (1), 153–158 (1998).
29. Bassnett S, Beebe D. Lens fibre differentiation. In: Development of the Ocular Lens. Lovicu FJ, Robinson ML (Eds). Cambridge University Press, Cambridge, UK, 214–244 (2004).
30. Foley JD, Rosenbaum H, Griep AE. Temporal regulation of VEID-7-amino-4-trifluoromethylcoumarin cleavage activity and caspase-6 correlates with organelle loss during lens development. J. Biol. Chem. 279 (31), 32142–32150 (2004).
31. Morozov V, Wawrousek EF. Caspase-dependent secondary lens fiber cell disintegration in αA-/αB-crystallin double-knockout mice. Development 133 (5), 813–821 (2006). Demonstrates that α-crystallin
32. Beere HM. The stress of dying: the role of heat shock proteins in the regulation of apoptosis. J. Cell Sci. 117 (Pt 13), 2641–2651 (2004).
33. Weber GF, Menko AS. The canonical intrinsic mitochondrial death pathway has a non-apoptotic role in signaling lens cell differentiation. J. Biol. Chem. 280 (23), 22135–22145 (2005).
34. Andersson M, Honarvar A, Sjostrand J, Peterson A, Karlsson JO. Decreased caspase-3 activity in human lens epithelium from posterior subcapsular cataracts. Exp. Eye Res. 76 (2), 175–182 (2003).
35. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C. Vital functions for lethal caspases. Oncogene 24 (33), 5137–5148 (2005).
36. Gong X, Cheng C, Xia CH. Connexins in lens development and cataractogenesis. J. Membr. Biol. DOI: 17578632 (2007) (Epub ahead of print).
37. Yin X, Gu S, Jiang JX. The development-associated cleavage of lens connexin 45.6 by caspase-3-like protease is regulated by casein kinase II-mediated phosphorylation. J. Biol. Chem. 276 (37), 34567–34572 (2001).
38. Lee A, Morrow JS, Fowler VM. Caspase remodeling of the spectrin membrane skeleton during lens development and aging. J. Biol. Chem. 276 (23), 20735–20742 (2001).
39. Andersson M, Sjostrand J, Petersen A, Honarvar AK, Karlsson JO. Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 41 (9), 2623–2632 (2000).
40. Varshavsky A. Regulated protein degradation. Trends Biochem. Sci. 30 (6), 283–286 (2005).
41. Girao H, Pereira P, Taylor A, Shang F. Subcellular redistribution of components of the ubiquitin-proteasome pathway during lens differentiation and maturation. Invest. Ophthalmol. Vis. Sci. 46 (4), 1386–1392 (2005).
42. Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 462 (2), 245–253 (2007).
43. Mijaljica D, Prescott M, Devenish RJ. Different fates of mitochondria: alternative ways for degradation? Autophagy 3 (1), 4–9 (2007).
44. Matsui M, Yamamoto A, Kuma A, Ohsumi Y, Mizushima N. Organelle degradation during the lens and erythroid differentiation is independent of autophagy. Biochem. Biophys. Res. Commun. 339 (2), 485–489 (2006).
45. Mijaljica D, Prescott M, Devenish RJ. Nibbling within the nucleus: turnover of nuclear contents. Cell. Mol. Life Sci. 64 (5), 581–588 (2007).
46. Zetterberg M, Petersen A, Sjostrand J, Karlsson J. Proteasome activity in human lens nuclei and correlation with age, gender and severity of cataract. Curr. Eye Res. 27 (1), 45–53 (2003).
47. Dudek EJ, Shang F, Valverde P, Liu Q, Hobbs M, Taylor A. Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases. FASEB J. 19 (12), 1707–1709 (2005).
48. Petersen A, Zetterberg M, Sjostrand J, Karlsson JO. A new model for assessing proteolysis in the intact mouse lens in organ culture. Ophthalmic Res. 36 (1), 25–30 (2004).
49. Chwieralski CE, Welte T, Buhling F. Cathepsin-regulated apoptosis. Apoptosis 11 (2), 143–149 (2006).
50. Zuzarte-Luis V, Montero JA, Kawakami Y, Izpisua-Belmonte JC, Hurle JM. Lysosomal cathepsins in embryonic programmed cell death. Dev. Biol. 301 (1), 205–217 (2007).
51. Zuzarte-Luis V, Montero JA, Torre-Perez N, Garcia-Porrero JA, Hurle JM. Cathepsin D gene expression outlines the areas of physiological cell death during embryonic development. Dev. Dyn. 236 (3), 880–885 (2007).
52. Im E, Kazlauskas A. The role of cathepsins in ocular physiology and pathology. Exp. Eye Res. 84 (3), 383–388 (2007).
53. Nishimoto S, Kawane K, Watanabe-Fukunaga R et al. Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature 424 (6952), 1071–1074 (2003).
54. Nakahara M, Nagasaka A, Koike M et al. Degradation of nuclear DNA by DNase II-like acid DNase in cortical fiber cells of mouse eye lens. FEBS. J. (2007).
55. Saez ME, Ramirez-Lorca R, Moron FJ, Ruiz A. The therapeutic potential of the calpain family: new aspects. Drug Discov. Today 11 (19–20), 917–923 (2006).
56. Biswas S, Harris F, Dennison S, Singh J, Phoenix DA. Calpains: targets of cataract prevention? Trends Mol. Med. 10 (2), 78–84 (2004).
57. Biswas S, Harris F, Dennison S, Singh JP, Phoenix D. Calpains: enzymes of vision? Med. Sci. Monit. 11 (9), RA301 –RA310 (2005).
58. Abell AD, Jones MA, Neffe AT et al. Investigation into the P3 binding domain of m-calpain using photoswitchable diazo- and triazene-dipeptide aldehydes: new anticataract agents. J. Med. Chem. 50 (12), 2916–2920 (2007).
59. Ma H, Fukiage C, Kim YH et al. Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization. J. Biol. Chem. 276 (30), 28525–28531 (2001).
60. 2+ regulation in differentiating lens cells in culture. Exp. Eye Res. 75 (1), 77–85 (2002).
61. Robertson LJ, Morton JD, Yamaguchi M, Bickerstaffe R, Shearer TR, Azuma M. Calpain may contribute to hereditary cataract formation in sheep. Invest. Ophthalmol. Vis. Sci. 46 (12), 4634–4640 (2005).
62. Wei CJ, Xu X, Lo CW. Connexins and cell signaling in development and disease. Annu. Rev. Cell Dev. Biol. 20, 811–838 (2004).
63. Baruch A, Greenbaum D, Levy ET et al. Defining a link between gap junction communication, proteolysis, and cataract formation. J. Biol. Chem. 276 (31), 28999–29006 (2001).
64. Gao J, Sun X, Martinez-Wittinghan FJ, Gong X, White TW, Mathias RT. Connections between connexins, calcium, and cataracts in the lens. J. Gen. Physiol. 124 (4), 289–300 (2004).
65. 2+-induced protein loss, vimentin cleavage and opacification. Invest. Ophthalmol. Vis. Sci. 41 (8), 2255–2261 (2000).
66. Reed NA, Castellini MA, Ma H, Shearer TR, Duncan MK. Protein expression patterns for ubiquitous and tissue specific calpains in the developing mouse lens. Exp. Eye Res. 76 (4), 433–443 (2003).
67. Ma H, Shih M, Fukiage C et al. Influence of specific regions in Lp82 calpain on protein stability, activity, and localization within lens. Invest. Ophthalmol. Vis. Sci. 41 (13), 4232–4239 (2000).
68. Inomata M, Hayashi M, Ito Y et al. Comparison of Lp82- and m-calpain-mediated proteolysis during cataractogenesis in Shumiya cataract rat (SCR). Curr. Eye Res. 25 (4), 207–213 (2002).
69. Biswas S, Harris F, Singh J, Phoenix D. Role of calpains in diabetes mellitus-induced cataractogenesis: a mini review. Mol. Cell Biochem. 261 (1–2), 151–159 (2004).
70. Nishikiori N, Osanai M, Chiba H, Kojima T, Ohguro H, Sawada N. Inhibitory effects of retinoic acid receptor α stimulants on murine cataractogenesis through suppression of deregulated calpains. Invest. Ophthalmol. Vis. Sci. 48 (5), 2224–2229 (2007).
71. Tamiya S, Wormstone IM, Marcantonio JM, Gavrilovic J, Duncan G. Induction of matrix metalloproteinases 2 and 9 following stress to the lens. Exp. Eye Res. 71 (6), 591–597 (2000).
72. Sachdev NH, Di Girolamo N, Nolan TM, McCluskey PJ, Wakefield D, Coroneo MT. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the human lens: implications for cortical cataract formation. Invest. Ophthalmol. Vis. Sci. 45 (11), 4075–4082 (2004).
73. John M, Jaworski C, Chen Z et al. Matrix metalloproteinases are down-regulated in rat lenses exposed to oxidative stress. Exp. Eye Res. 79 (6), 839–846 (2004).
74. Dwivedi DJ, Pino G, Banh A et al. Matrix metalloproteinase inhibitors suppress transforming growth factor-β-induced subcapsular cataract formation. Am. J. Pathol. 168 (1), 69–79 (2006).
75. Huovila AP, Turner AJ, Pelto-Huikko M, Karkkainen I, Ortiz RM. Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30 (7), 413–422 (2005).
76. Lim JM, Lee JH, Wee WR, Joo CK. Downregulated expression of ADAM9 in anterior polar cataracts. J. Cataract Refract Surg. 28 (4), 697–702 (2002).
77. Watabe-Uchida M, Masuda A, Shimada N et al. Novel metalloprotease-disintegrin, meltrin epsilon (ADAM35), expressed in epithelial tissues during chick embryogenesis. Dev. Dyn. 230 (3), 557–568 (2004).
78. Dagoneau N, Benoist-Lasselin C, Huber C et al. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. Am. J. Hum. Genet. 75 (5), 801–806 (2004).
79. Li G, Percontino L, Sun Q, Qazi AS, Frederikse PH. β-amyloid secretases and β-amloid degrading enzyme expression in lens. Mol. Vis. 9, 179–183 (2003).
80. Pandey SK, Apple DJ, Werner L, Maloof AJ, Milverton EJ. Posterior capsule opacification: a review of the aetiopathogenesis, experimental and clinical studies and factors for prevention. Indian J. Ophthalmol. 52 (2), 99–112 (2004).
81. Malecaze F, Decha A, Serre B et al. Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells. Gene Ther. 13 (5), 440–448 (2006).
82. Malecaze F, Lubsen NH, Serre B et al. Lens cell targetting for gene therapy of prevention of posterior capsule opacification. Gene Ther. 13 (19), 1422–1429 (2006).
83. Seomun Y, Kim J, Lee EH, Joo CK. Overexpression of matrix metalloproteinase-2 mediates phenotypic transformation of lens epithelial cells. Biochem. J. 358 (Pt 1), 41–48 (2001).
84. Hosler MR, Wang-Su ST, Wagner BJ. Role of the proteasome in TGF-β signaling in lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 47 (5), 2045–2052 (2006).
85. Awasthi N, Wagner BJ. Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification. Invest. Ophthalmol. Vis. Sci. 47 (10), 4482–4489 (2006).
86. Wormstone IM, Tamiya S, Anderson I, Duncan G. TGF-β2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest. Ophthalmol. Vis. Sci. 43 (7), 2301–2308 (2002).
87. Wong TT, Daniels JT, Crowston JG, Khaw PT. MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule. Br. J. Ophthalmol. 88 (7), 868–872 (2004).
88. Dawes LJ, Elliott RM, Reddan JR, Wormstone YM, Wormstone IM. Oligonucleotide microarray analysis of human lens epithelial cells: TGFβ regulated gene expression. Mol. Vis. 13, 1181–1197 (2007).
89. Jiang Q, Zhou C, Bi Z, Wan Y. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells. J. Ocul. Pharmacol. Ther. 22 (2), 93–102 (2006).
90. Franco SJ, Huttenlocher A. Regulating cell migration: calpains make the cut. J. Cell Sci. 118 (Pt 17), 3829–3838 (2005).
91. Carragher NO. Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr. Pharm. Des. 12 (5), 615–638 (2006).
92. Glass AS, Dahm R. The zebrafish as a model organism for eye development. Ophthalmic Res. 36 (1), 4–24 (2004).
93. Dahm R, Schonthaler HB, Soehn AS, van Marle J, Vrensen GF. Development and adult morphology of the eye lens in the zebrafish. Exp. Eye Res. 85 (1), 74–89 (2007).
94. Zhao H, Yang Y, Partanen J, Ciruna BG, Rossant J, Robinson ML. Fibroblast growth factor receptor 1 (Fgfr1) is not essential for lens fiber differentiation in mice. Mol. Vis. 12, 15–25 (2006).